Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma
Clinical trial NCT00217438 · COMPLETED
Trial details
- NCT number
- NCT00217438
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2012-10-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.